Obesity-related changes in high-density lipoprotein metabolism
Obesity is associated with a 3-or-more-fold increase in the risk of fatal and nonfatal myocardial infarction (1,2,3,4,5,6). The American Heart Association has reclassified obesity as a major, modifiable risk factor for coronary heart disease (7). The increased prevalence of premature coronary heart disease in obesity is attributed to multiple factors (8,9,10). A principal contributor to this serious morbidity is the alterations in plasma lipid and lipoprotein levels. The dyslipidemia of obesity is commonly manifested as high plasma triglyceride levels, low high-density lipoprotein cholesterol (HDLc), and normal low-density lipoprotein cholesterol (LDLc) with preponderance of small dense LDL particles (7,8,9,10). However, there is a considerable heterogeneity of plasma lipid profile in overweight and obese people. The precise cause of this heterogeneity is not entirely clear but has been partly attributed to the degree of visceral adiposity and insulin resistance. The emergence of glucose intolerance or a genetic predisposition to familial combined hyperlipidemia will further modify the plasma lipid phenotype in obese people (11,12,13,14,15).
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2008 |
---|---|
Erschienen: |
2008 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Obesity (Silver Spring, Md.) - 16(2008), 6 vom: 23. Juni, Seite 1152-60 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mooradian, Arshag D [VerfasserIn] |
---|
Links: |
---|
Themen: |
Apolipoprotein A-I |
---|
Anmerkungen: |
Date Completed 08.09.2008 Date Revised 31.03.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/oby.2008.202 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM178703575 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM178703575 | ||
003 | DE-627 | ||
005 | 20231223152541.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231223s2008 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/oby.2008.202 |2 doi | |
028 | 5 | 2 | |a pubmed24n0596.xml |
035 | |a (DE-627)NLM178703575 | ||
035 | |a (NLM)18388903 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mooradian, Arshag D |e verfasserin |4 aut | |
245 | 1 | 0 | |a Obesity-related changes in high-density lipoprotein metabolism |
264 | 1 | |c 2008 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.09.2008 | ||
500 | |a Date Revised 31.03.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Obesity is associated with a 3-or-more-fold increase in the risk of fatal and nonfatal myocardial infarction (1,2,3,4,5,6). The American Heart Association has reclassified obesity as a major, modifiable risk factor for coronary heart disease (7). The increased prevalence of premature coronary heart disease in obesity is attributed to multiple factors (8,9,10). A principal contributor to this serious morbidity is the alterations in plasma lipid and lipoprotein levels. The dyslipidemia of obesity is commonly manifested as high plasma triglyceride levels, low high-density lipoprotein cholesterol (HDLc), and normal low-density lipoprotein cholesterol (LDLc) with preponderance of small dense LDL particles (7,8,9,10). However, there is a considerable heterogeneity of plasma lipid profile in overweight and obese people. The precise cause of this heterogeneity is not entirely clear but has been partly attributed to the degree of visceral adiposity and insulin resistance. The emergence of glucose intolerance or a genetic predisposition to familial combined hyperlipidemia will further modify the plasma lipid phenotype in obese people (11,12,13,14,15) | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 7 | |a Apolipoprotein A-I |2 NLM | |
650 | 7 | |a Apolipoproteins |2 NLM | |
650 | 7 | |a Cholesterol, HDL |2 NLM | |
650 | 7 | |a Lipoproteins, HDL |2 NLM | |
700 | 1 | |a Haas, Michael J |e verfasserin |4 aut | |
700 | 1 | |a Wehmeier, Kent R |e verfasserin |4 aut | |
700 | 1 | |a Wong, Norman C W |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Obesity (Silver Spring, Md.) |d 2006 |g 16(2008), 6 vom: 23. Juni, Seite 1152-60 |w (DE-627)NLM160857384 |x 1930-739X |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2008 |g number:6 |g day:23 |g month:06 |g pages:1152-60 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/oby.2008.202 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2008 |e 6 |b 23 |c 06 |h 1152-60 |